U-CaVIT device vs standard care for preventing heavy bleeding after c-section
Part of Women’s health & pregnancy clinical trials.
This study tests a new device called U-CaVIT to prevent heavy bleeding after a planned cesarean delivery in women at high risk. It compares the U-CaVIT device to standard care to see which works better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are at least 30 weeks pregnant on the day of delivery
- Your pregnancy is ongoing (vital)
- You are scheduled for a planned cesarean delivery (not an emergency)
- You have at least one risk factor for heavy bleeding: previous heavy bleeding, obesity (BMI 30+), 4 or more previous births, age 45+, multiple pregnancy, too much amniotic fluid, or a suspected large baby (≥4500g)
- You are not participating in another research study and can understand English or German
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two medications given right after vaginal delivery to prevent heavy bleeding (postpartum hemorrhage). The goal is to find which one works better for women who have a higher risk of bleeding after childbirth.
This study compares two medical devices used to start labor in women who have had one previous C-section and whose cervix is not yet ready. It aims to find which device works best for safely inducing labor.
This trial tests if giving calcium through an IV before a C-section can help reduce blood loss in women at higher risk for heavy bleeding due to the uterus not contracting well.
This trial tests two medicines given during a planned C-section to see which is better at preventing heavy bleeding. It may help make delivery safer for healthy women having a scheduled cesarean.
This trial studies whether tranexamic acid can prevent heavy bleeding after a planned or urgent cesarean delivery in people with placenta previa. If you qualify, you may receive the study drug to help your body keep blood loss lower during and after surgery.
This study compares two medicines—carbetocin and oxytocin—given during a planned cesarean to help prevent heavy bleeding after delivery. It is for women who have certain risk factors for uterine atony (when the uterus does not tighten up after birth).
Hear when a new Postpartum Hemorrhage (Primary) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.